FR-182980 is an orally active ACAT1 inhibitor ( IC 50 : 30 nM). FR-182980 has hypocholesterolemic activity and can be used for research of atherosclerosis.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Acyltransferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.